<div class="container">

<table style="width: 100%;"><tr>
<td>apri</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>
Calculate APRI (AST to Platelet Ratio)
</h2>

<h3>Description</h3>

<p>Using aspartate aminotransferase and platelet values, calculate the APRI index, devised by Wait et al 2003, estimates hepatic fibrosis and cirrhosis in patients with hepatitis C. APRI value &lt;0.7 is indicative of little to no evidence of fibrosis, 0.7-1.0 is moderate fibrosis, and 1.0+ is evidence of cirrhosis and significant fibrosis, as validated by Khan et al. 2008 and Lin et al 2011.
</p>


<h3>Usage</h3>

<pre><code class="language-R">apri(ast, plt)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>ast</code></td>
<td>

<p>Numeric value of aspartate aminotransferase in U/L.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>plt</code></td>
<td>

<p>Numeric value of platelets in 10^3/uL or 10^9/L.
</p>
</td>
</tr>
</table>
<h3>Value</h3>

<p>A numeric value/vector with predicted APRI index score.
</p>


<h3>References</h3>

<p>Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518-526. doi:10.1053/jhep.2003.50346
Khan DA, Fatima-Tuz-Zuhra, Khan FA, Mubarak A. Evaluation of diagnostic accuracy of APRI for prediction of fibrosis in hepatitis C patients. J Ayub Med Coll Abbottabad. 2008;20(4):122-126.
Lin, Z.-H., Xin, Y.-N., Dong, Q.-J., Wang, Q., Jiang, X.-J., Zhan, S.-H., Sun, Y. and Xuan, S.-Y. (2011), Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: An updated meta-analysis. Hepatology, 53: 726-736. https://doi.org/10.1002/hep.24105
</p>


<h3>Examples</h3>

<pre><code class="language-R">
# The function is defined as
apri(16,150)

</code></pre>


</div>